Literature DB >> 11706985

Natural peptide analgesics: the role of solution conformation.

R Spadaccini1, P A Temussi.   

Abstract

Endogenous opioids have been studied extensively since their discovery, in the hope of finding a perfect analgesic, devoid of the secondary effects of alkaloid opioids. However, the design of selective opioid agonists has proved very difficult. First, structural studies of peptides in general are hampered by their intrinsic flexibility. Second, the relationship between constitution and the so-called 'bioactive conformation' is far from obvious. Ideally, a direct structural study of the complex between a peptide and its receptor should answer both questions, but such a study is not possible, because opioid receptors are large membrane proteins, difficult to study by standard structural techniques. Thus, conformational studies of opioid peptides are still important for drug design and also for indirect receptor mapping. This review deals with conformational studies of natural opioid peptides in several solvents that mimic in part the different environments in which the peptides exert their action. None of the structural investigations yields a convincing bioactive conformation, but the global conformation of longer peptides in biomimetic environments can shed light on the interaction with receptors.

Mesh:

Substances:

Year:  2001        PMID: 11706985     DOI: 10.1007/PL00000797

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  3 in total

1.  The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.

Authors:  Takashi Yamamoto; Padma Nair; Neil E Jacobsen; Peg Davis; Shou-wu Ma; Edita Navratilova; Sharif Moye; Josephine Lai; Henry I Yamamura; Todd W Vanderah; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2008-09-27       Impact factor: 7.446

2.  The conformation of enkephalin bound to its receptor: an "elusive goal" becoming reality.

Authors:  Domenico Sanfelice; Piero A Temussi
Journal:  Front Mol Biosci       Date:  2014-10-07

3.  Cystobactamid 507: Concise Synthesis, Mode of Action, and Optimization toward More Potent Antibiotics.

Authors:  Walid A M Elgaher; Mostafa M Hamed; Sascha Baumann; Jennifer Herrmann; Lorenz Siebenbürger; Jana Krull; Katarina Cirnski; Andreas Kirschning; Mark Brönstrup; Rolf Müller; Rolf W Hartmann
Journal:  Chemistry       Date:  2020-04-28       Impact factor: 5.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.